Posted in Liver Cancer

Recent research has shown that immunotherapy given before surgery caused liver cancer tumours to die off in one-third of the patients enrolled in a first-of-its-kind clinical trial. Mount Sinai researchers reported their findings in The Lancet Gastroenterology & Hepatology - January 2022 The phase 2 trial results suggested that the neo-adjuvant immunotherapy -- therapy given before surgery -- may kill not only the tumour, but also microscopic cancer cells that surgery would miss and tha...